[{"id":"da41551a-8725-4ada-8cf7-99ed7c4f6360","acronym":"","url":"https://clinicaltrials.gov/study/NCT04739111","created_at":"2022-06-29T09:02:24.631Z","updated_at":"2024-07-02T16:36:34.938Z","phase":"Phase 1","brief_title":"An Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant Tumor","source_id_and_acronym":"NCT04739111","lead_sponsor":"Dragonboat Biopharmaceutical Company Limited","biomarkers":" RAS","pipe":"","alterations":" ","tags":["RAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BC001 (cetuximab biosimilar) • lesabelimab (BC003)"],"overall_status":"Recruiting","enrollment":" Enrollment 130","initiation":"Initiation: 01/29/2021","start_date":" 01/29/2021","primary_txt":" Primary completion: 02/01/2023","primary_completion_date":" 02/01/2023","study_txt":" Completion: 02/01/2024","study_completion_date":" 02/01/2024","last_update_posted":"2021-02-08"}]